Improving Actionable Biomarker Testing Through Technology-Enabled Solutions Grant

The Quality Improvement grant from Conquer Cancer and Pfizer aims to enhance biomarker testing and treatment practices in cancer care through innovative digital solutions. Targeting colorectal, lung, and prostate cancers, this initiative seeks proposals with measurable outcomes and strategies for sustainability. Applicants are encouraged to demonstrate how their findings can be shared across healthcare systems, ensuring broader impacts on patient care and outcomes. This collaboration reflects a commitment to improving cancer care through technology.

About Pfizer External Research & Grants
Pfizer External Research & Grants (ER&G) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
About Conquer Cancer, the ASCO Foundation
Conquer Cancer®, the ASCO Foundation, funds research for every cancer, every patient, everywhere. Since 1984, its Grants & Awards program has awarded more than $203 million through more than 9,800 grants and awards to improve cancer care and accelerate breakthroughs in clinical and translational oncology research.
Improving Actionable Biomarker Testing Through Technology-Enabled Solutions
Overview
Conquer Cancer®, the ASCO Foundation and Pfizer Inc. are collaborating to offer a Quality Improvement grant funding opportunity for healthcare systems, hospitals, cancer centers and other patient care delivery organizations to leverage digital technology to improve evidencebased biomarker testing and treatment practices, with a focus on colorectal, lung, and/or prostate cancer.
Project Outcomes and Sustainability
This RFP seeks to support initiatives that demonstrate clearly defined, measurable outcomes and robust plans for long-term sustainability. Preference will be given to proposals that articulate specific success metrics and proactively address how their programs will remain viable.
Applicants are also encouraged to consider how insights and learning from their projects may be transferable to other institutions or healthcare systems.